Liraglutide inhibits the proliferation of rat hepatic stellate cells under high glucose conditions by suppressing the ERK signaling pathway
Abstract Liver fibrosis is a common complication of diabetes. Due to the crucial role of HSCs in the pathogenesis of hepatic fibrosis, they are considered a key target in anti-fibrosis research. We designed this experiment to investigate the effects of liraglutide on the proliferation of rat hepatic...
Saved in:
| Main Authors: | Bingge Fan, Lingbing Meng, Xiao Zheng, Lei Bai, Yaping Du, Haiyan Ding, Yu Chen, Yuna Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-97872-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tanshinone IIA alleviates liver fibrosis by suppressing hepatic stellate cell proliferation via ERK/cyclin D1/p-Smad3L signaling axis
by: Wenjing Liao, et al.
Published: (2025-05-01) -
Magnoflorine ameliorates hepatic fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway
by: Meiling Zhang, et al.
Published: (2024-11-01) -
Effect of T lymphocyte on hepatic stellate cell activation in liver fibrosis
by: GONG Xiaoqian, et al.
Published: (2025-04-01) -
Inhibiting CXCR6 promotes senescence of activated hepatic stellate cells with limited proinflammatory SASP to attenuate hepatic fibrosis
by: Sheng Liqin, et al.
Published: (2025-08-01) -
Therapeutic Potential of PDA@CeO2 in Suppressing Hepatic Stellate Cell Activation and Preventing Liver Fibrosis
by: Li HM, et al.
Published: (2025-07-01)